Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 12/20 | 0.58 |
| ▸ | MMP9 | P14780 | 10/20 | 0.58 |
| ▸ | MMP1 | P03956 | 7/20 | 0.58 |
| ▸ | MMP3 | P08254 | 6/20 | 0.58 |
| ▸ | MMP7 | P09237 | 3/20 | 0.58 |
| ▸ | REN | P00797 | 3/20 | 0.54 |
| ▸ | MMP13 | P45452 | 7/20 | 0.50 |
| ▸ | MMP14 | P50281 | 6/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.44 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.44 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4499196 | 1.00 | MMP2 (0.58) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4508093 | 0.88 | REN (0.59) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4508089 | 0.88 | REN (0.59) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4504406 | 0.86 | REN (0.53) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4504408 | 0.86 | REN (0.53) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4502144 | 0.86 | REN (0.57) | MMP2MMP9MMP1MMP3REN | |
| SCHEMBL4502147 | 0.86 | REN (0.57) | MMP2MMP9MMP1MMP3REN | |
| SCHEMBL1913227 | 0.84 | REN (0.78) | MMP2MMP9MMP1MMP3MMP7 | |
| SCHEMBL4504389 | 0.83 | DPP4 (0.48) | RENALDH1A1TSHR | |
| SCHEMBL4504392 | 0.83 | DPP4 (0.48) | RENALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090233920-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-09-17 | — | — | US | claimed |
| EP-1907359-A2 | 3,5-SUBSTITUTED PIPERIDINE DERIVATIVES EFFECTIVE ON RENIN-RELATED DISORDERS | Novartis AG (CH) | 2008-04-09 | — | — | EP | claimed |
| WO-2007006534-A2 | PIPERIDINE DERIVATIVES USEFUL IN THE DIAGNOSTIC AND THERAPEUTIC TREATMENT OF DISEASES DEPENDING ON RENIN ACTIVITY | NOVARTIS AG (CH) | 2007-01-18 | — | — | WO | claimed |
| US-20090233920-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-09-17 | — | — | US | disclosed |
| EP-1907359-A2 | 3,5-SUBSTITUTED PIPERIDINE DERIVATIVES EFFECTIVE ON RENIN-RELATED DISORDERS | Novartis AG (CH) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007006534-A2 | PIPERIDINE DERIVATIVES USEFUL IN THE DIAGNOSTIC AND THERAPEUTIC TREATMENT OF DISEASES DEPENDING ON RENIN ACTIVITY | NOVARTIS AG (CH) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233920-A1 | ORGANIC COMPOUNDS | REN, ACE, AGTR1 | MMP2 310/4885MMP9 693/4885MMP1 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.